AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

AtaiBeckley solidifies position as a global leader in transformative mental health therapies with a short psychedelic durationBPL-003 (mebufotenin benzoate nasal spray) granted Breakthrough Therapy ...